infectious diseases, this ERS Monograph aims to provide an up-to-date and comprehensive overview of SARS, MERS and other viral respiratory infections, including seasonal influenza, avian influenza, RSV and HRV through six chapters written by authoritative experts from around the globe. We are most grateful to all the authors for their enormous contribution to this excellent book. We believe the selected topics will be of immense interest to all clinicians and scientists in the field. Disclosures: S.L. Johnston reports receiving grants and personal fees from Centocor, Sanofi Pasteur, GSK, Chiesi, Boehringer Ingelheim and Novartis. He has also received personal fees from Grünenthal. He has received grants, personal fees and holds shares in Synairgen. In addition, S.L. Johnston has the following licensed patents. Blair ED, Killington RA, Rowlands DJ, Clarke NJ, Johnston SL. Transgenic animal models of HRV with human ICAM-1 sequences. UK patent application no. 02 167 29.4, 18 July 2002 and International patent application No. PCT/EP2003/007939, 17 July 2003 Wark PA, Johnston SL, Holgate ST, Davies DE. Anti- virus therapy for respiratory diseases. UK patent application no. GB 0405634.7, 12 March 2004 Wark PA, Johnston SL, Holgate ST, Davies DE. Interferon-beta for anti-virus therapy for respiratory diseases. International patent application no. PCT/GB05/50031, 12 March 2004 Wark PA, Johnston SL, Holgate ST, Davies DE. The use of interferon lambda for the treatment and prevention of virally-induced exacerbation in asthma and chronic pulmonary obstructive disease. UK patent application no. 0518425.4, 9 September 2005 Wark PA, Johnston SL, Holgate ST, Davies DE. Anti-virus therapy for respiratory diseases. US patent application - 11/517,763, patent no. 7569216, national phase of PCT/GB2005/050031, 04 August 2009 Wark PA, Johnston SL, Holgate ST, Davies DE. Interferon-beta for anti-virus therapy for respiratory diseases. European patent number 1734987, 5 May 2010 Wark PA, Johnston SL, Holgate ST, Davies DE. Anti-virus therapy for respiratory diseases (IFNb therapy) Hong Kong patent number 1097181, 31 August 2010 Wark PA, Johnston SL, Holgate ST, Davies DE. Anti-virus therapy for respiratory diseases (IFNb therapy). Japanese patent number 4807526, 26 August 2011 Wark PA, Johnston SL, Holgate ST, Davies DE. Interferon-beta for anti-Virus therapy for respiratory dseases. New Hong Kong - Divisional patent application no. 11100187.0, 10 January 2011. S.L. Johnston also has the following patent pending. Burdin N, Almond J, Lecouturieir V, Girerd-Chambaz Y, Guy B, Bartlett N, Walton R, McLean G, Glanville N, Johnston SL. Induction of cross-reactive cellular response against rhinovirus antigens. European Patent Number 13305152, 4 April 2013. x
Previous Page Next Page